According to the American Diabetes Association, T1DM is defined as autoimmune β-cells destruction and death, typically resulting in absolute insulin deficiency, and T2DM is distinguished by a persistent reduction of β-cells mass loss and a progressive loss of insulin secretion. This evidence concerns the gene INS and type 1 diabetes mellitus.